Home > Annual Financials > TATVA CHINTAN PHARMA CHEM

TATVA CHINTAN PHARMA CHEM Financial Statement Analysis
[BOM: 543321|NSE : TATVA]

The Revenues of TATVA CHINTAN PHARMA CHEM have decreased by -2.31% YoY .
The Earnings Per Share (EPS) of TATVA CHINTAN PHARMA CHEM has decreased by -36.74 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

TATVA CHINTAN PHARMA CHEM Last 5 Annual Financial Results
[BOM: 543321|NSE : TATVA]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹424 Cr₹434 Cr₹300 Cr₹263 Cr₹206 Cr
Expenses ₹363 Cr₹325 Cr₹234 Cr₹208 Cr₹172 Cr
Operating Profit (Excl OI) ₹61 Cr₹109 Cr₹67 Cr₹55 Cr₹34 Cr
Other Income ₹5.74 Cr₹9.02 Cr₹5.20 Cr₹1.38 Cr₹0.49 Cr
Interest ₹8.60 Cr₹5.23 Cr₹4.45 Cr₹4.27 Cr₹3.95 Cr
Depreciation ₹9.56 Cr₹8.18 Cr₹6.73 Cr₹4.79 Cr₹4.02 Cr
Profit Before Tax ₹45 Cr₹104 Cr₹61 Cr₹48 Cr₹27 Cr
Profit After Tax ₹45 Cr₹96 Cr₹52 Cr₹38 Cr₹21 Cr
Consolidated Net Profit ₹45 Cr₹96 Cr₹52 Cr₹38 Cr₹21 Cr
Earnings Per Share (Rs)₹12.98₹20.52₹43.25₹26.02₹47.03
PAT Margin (%)7.6910.7322.1017.3814.36
ROE(%)4.859.2130.0136.8538.29
ROCE(%)7.008.3525.7528.0428.40
Total Debt/Equity(x)0.020.330.250.540.77

Key Financials

Market Cap : ₹ 2,653.7 Cr
Revenue (TTM) : ₹ 394.1 Cr
Net Profit(TTM) : ₹ 7.2 Cr
EPS (TTM) : ₹ 3.1
P/E (TTM) : 370.9

Industry Peers & Returns1W1M1Y
TATVA CHINTAN PHARMA CHEM 9.6% 20.3% 15.7%
PIDILITE INDUSTRIES -1.9% -5.7% -7.2%
SRF -2.6% -3.6% 26.7%
SOLAR INDUSTRIES INDIA -3.3% -17.5% 42%
GUJARAT FLUOROCHEMICALS -2.7% -2% 11%
GODREJ INDUSTRIES -0.9% -9.1% 27.2%
DEEPAK NITRITE -3.7% -6.4% -35.6%
TATA CHEMICALS -2.9% 0% -10%
HIMADRI SPECIALITY CHEMICAL -6.2% -4.6% 23.8%


TATVA CHINTAN PHARMA CHEM Revenues
[BOM: 543321|NSE : TATVA]

Y-o-Y

-2.31 %

5 Yr CAGR

19.71 %

Years Revenues % Change
Mar2024 ₹424 Cr
-2.31
Mar2023 ₹434 Cr
44.38
Mar2022 ₹300 Cr
14.10
Mar2021 ₹263 Cr
27.60
Mar2020 ₹206 Cr -


TATVA CHINTAN PHARMA CHEM Operating Profit
[BOM: 543321|NSE : TATVA]

Y-o-Y

-43.99 %

5 Yr CAGR

15.53 %

Years Operating Profit % Change
Mar2024 ₹61 Cr
-43.99
Mar2023 ₹109 Cr
62.75
Mar2022 ₹67 Cr
20.63
Mar2021 ₹55 Cr
62.03
Mar2020 ₹34 Cr -

Operating Margins
Y-o-Y

-42.65 %

5 Yr CAGR

-3.49 %

Years Operating Margin% % Change
Mar2024 14.35%
-42.65
Mar2023 25.02%
12.70
Mar2022 22.2%
5.71
Mar2021 21%
26.96
Mar2020 16.54% -

TATVA CHINTAN PHARMA CHEM Profit After Tax
[BOM: 543321|NSE : TATVA]

Y-o-Y

-52.56 %

5 Yr CAGR

21.98 %

Years Profit After Tax % Change
Mar2024 ₹45 Cr
-52.56
Mar2023 ₹96 Cr
83.45
Mar2022 ₹52 Cr
38.30
Mar2021 ₹38 Cr
83.95
Mar2020 ₹21 Cr -

PAT Margins
Y-o-Y

-28.33 %

5 Yr CAGR

-14.46 %

Years PAT Margin(%) % Change
Mar2024 7.69 %
-28.33
Mar2023 10.73 %
-51.45
Mar2022 22.1 %
27.16
Mar2021 17.38 %
21.03
Mar2020 14.36 % -

TATVA CHINTAN PHARMA CHEM Earnings Per Share (EPS)
[BOM: 543321|NSE : TATVA]

Y-o-Y

-36.74 %

5 Yr CAGR

-27.52 %

Years EPS % Change
Mar2024 ₹13
-36.74
Mar2023 ₹21
-52.55
Mar2022 ₹43
66.22
Mar2021 ₹26
-44.67
Mar2020 ₹47 -

TATVA CHINTAN PHARMA CHEM Return on Capital Employed (ROCE)
[BOM: 543321|NSE : TATVA]

Y-o-Y

-16.17 %

5 Yr CAGR

-29.54 %

Years ROCE % Change
Mar2024 7%
-16.17
Mar2023 8.35%
-67.57
Mar2022 25.75%
-8.17
Mar2021 28.04%
-1.27
Mar2020 28.4% -

TATVA CHINTAN PHARMA CHEM Share Price vs Sensex

Current Share Price : ₹1,134.1
Current MarketCap: ₹ 2,653.7 Cr
Updated EOD on :Jul 28,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
TATVA CHINTAN PHARMA CHEM

9.6%

20.3%

15.7%

SENSEX

-1.6%

-3.4%

0.9%

TATVA CHINTAN PHARMA CHEM related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE COMMODITIES -1.9% -0.6% 3.2%
BSE SMALLCAP -3.8% -1.4% -1.2%
No NSE index found

You may also like the below Video Courses


FAQ about TATVA CHINTAN PHARMA CHEM Financials


How the annual revenues of TATVA CHINTAN PHARMA CHEM have changed ?

The Revenues of TATVA CHINTAN PHARMA CHEM have decreased by -2.31% YoY .

How the Earnings per Share (EPS) of TATVA CHINTAN PHARMA CHEM have changed?

The Earnings Per Share (EPS) of TATVA CHINTAN PHARMA CHEM has decreased by -36.74 % YoY .